Searched over 200M research papers
7 papers analyzed
These studies suggest that vitamin B3, particularly in the form of nicotinamide, may reduce the risk of skin cancer by enhancing DNA repair, preventing UV-induced immunosuppression, and reducing the number of new non-melanoma skin cancers.
20 papers analyzed
The potential role of vitamin B3 (nicotinamide) in reducing the risk of skin cancer has been a subject of scientific investigation. This synthesis aims to present the key findings from multiple research papers to determine whether vitamin B3 can decrease the incidence of skin cancer.
Reduction in Non-Melanoma Skin Cancer (NMSC) Incidence:
Enhancement of DNA Repair and Prevention of UV-Induced Damage:
Correlation with HIF-1α and p53 Expression:
The collective findings from the research papers indicate that vitamin B3 (nicotinamide) can play a significant role in reducing the risk of non-melanoma skin cancers. This effect is primarily attributed to its ability to enhance DNA repair and prevent UV-induced immune suppression. Additionally, vitamin B3 supplementation appears to modulate the expression of key proteins associated with skin cancer progression, further supporting its protective role.
Most relevant research papers on this topic
What economic policies improve middle-class outcomes?
How does AI applied in manufacturing process
Can you target specific areas for weight loss?
bipolar disorder as a mitochondrial disorder
What are the symptoms of rectal cancer?
What are the implications of high fructose corn syrup on health?